Medidata Selected by Worldwide Clinical Trials to Accelerate Trials and Transform Patient Experience
14 5월 2024 - 9:00PM
Business Wire
Leading global CRO adopts Medidata AI for
better-informed trial planning
Medidata, a Dassault Systèmes brand and leading provider of
clinical trial solutions to the life sciences industry, today
announced an expansion of its relationship with Worldwide Clinical
Trials (“Worldwide”), a full-service global contract research
organization (CRO). The agreement will facilitate data-driven
decision-making across Worldwide’s entire clinical operations with
the implementation of Medidata AI and enable Worldwide to support
customers by reducing trial timelines and improving site
selection.
This new collaboration will catapult Worldwide into the next
phase of its data evolution, powered by Medidata’s artificial
intelligence solutions and its expansive historical data set, the
largest in the industry.
“Worldwide will accelerate clinical research and advance the
life sciences industry by leveraging site-level granularity and
real-time actionable observations provided by Medidata AI’s turnkey
solution,” says Tom Doyle, chief technology officer, Medidata.
"For over 10 years, we’ve partnered with Medidata to help our
customers gather advanced, data-driven insights so they can make
confident and well-informed decisions about the future direction of
their clinical trials,” says Peter Benton, president and CEO,
Worldwide Clinical Trials. “Incorporating Medidata AI Intelligent
Trials into our studies will allow us to more systematically plan,
design, and execute research so we can deliver a better experience
for patients and sponsors.”
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 33,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across 2,200+ customers
trust Medidata’s seamless, end-to-end platform to improve patient
experiences, accelerate clinical breakthroughs, and bring therapies
to market faster. A Dassault Systèmes brand (Euronext Paris:
FR0014003TT8, DSY.PA), Medidata is headquartered in New York City
and has been recognized as a Leader by Everest Group and IDC.
Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide
business and people with collaborative virtual environments to
imagine sustainable innovations. By creating virtual twin
experiences of the real world with our 3DEXPERIENCE platform and
applications, our customers can redefine the creation, production
and life-cycle-management processes of their offer and thus have a
meaningful impact to make the world more sustainable. The beauty of
the Experience Economy is that it is a human-centered economy for
the benefit of all – consumers, patients and citizens. Dassault
Systèmes brings value to more than 350,000 customers of all sizes,
in all industries, in more than 150 countries. For more
information, visit www.3ds.com
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS
logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA,
CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE,
SIMULIA and SOLIDWORKS are commercial trademarks or registered
trademarks of Dassault Systèmes, a European company (Societas
Europaea) incorporated under French law, and registered with the
Versailles trade and companies registry under number 322 306 440,
or its subsidiaries in the United States and/or other countries.
All other trademarks are owned by their respective owners. Use of
any Dassault Systèmes or its subsidiaries trademarks is subject to
their express written approval.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508504595/en/
Medidata PR Medidata.PR@3ds.com
Analyst Relations Medidata.AR@3ds.com
Destiny Media Technologies (TSXV:DSY)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Destiny Media Technologies (TSXV:DSY)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
